You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BMS-354825

Showing 1 - 25 of 919
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Cancer Trial in Houston (Dasatinib, Bevacizumab, Paclitaxel)

Completed
  • Advanced Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 21, 2022

Advanced Cancers Trial in Houston (Crizotinib, Dasatinib)

Completed
  • Advanced Cancers
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 29, 2022

Prostate Cancer Trial in Houston (Abiraterone Acetate, Prednisone, Sunitinib)

Active, not recruiting
  • Prostate Cancer
  • Abiraterone Acetate
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 6, 2022

Malignant Pleural Mesothelioma Trial in Houston (Dasatinib)

Active, not recruiting
  • Malignant Pleural Mesothelioma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 25, 2022

Prostate Cancer Trial in Los Angeles (degarelix, enzalutamide, trametinib)

Active, not recruiting
  • Prostate Cancer
  • Los Angeles, California
    University of California, Los Angeles
Aug 25, 2022

Breast Tumors, Triple Negative Breast Tumors Trial in Chicago, Madison (drug, procedure, other)

Terminated
Has Results
  • Breast Neoplasms
  • Triple Negative Breast Neoplasms
  • Chicago, Illinois
  • +1 more
Jun 2, 2022

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Jun 24, 2022

Leukemia Trial in Worldwide (Dasatinib)

Completed
Has Results
  • Leukemia
  • Vienna, Austria
  • +12 more
Feb 24, 2021

Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

EGFR Gene Mutation, Nonsmall Cell Lung Cancer Trial in Washington, Hackensack (Dasatinib, Osimertinib)

Active, not recruiting
  • EGFR Gene Mutation
  • Nonsmall Cell Lung Cancer
  • Washington, District of Columbia
  • +1 more
Jan 9, 2022

Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer AJCC v6 and v7 Trial in

Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • +3 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Dec 15, 2021

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

Terminated
Has Results
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +8 more
  • Duarte, California
    City of Hope Medical Center
Mar 28, 2022

Leukemia Trial in Los Angeles (dasatinib)

Completed
  • Leukemia
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center at UCLA
Jul 30, 2020

Refractory Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia Trial in

Completed
Has Results
  • Refractory Chronic Lymphocytic Leukemia
  • +4 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Mar 15, 2021

Philadelphia Positive Acute Lymphoblastic Leukemia Trial in Germany (Dasatinib)

Completed
  • Philadelphia Positive Acute Lymphoblastic Leukemia
  • Stuttgart, Baden-Württemberg, Germany
  • +21 more
Jan 10, 2022

Breast Cancer Trial in Houston (Dasatinib, AZD6244)

Terminated
Has Results
  • Breast Cancer
  • Houston, Texas
    UT MD Anderson Cancer Center
Sep 1, 2020

B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Recurrent B Acute

Recruiting
  • B Acute Lymphoblastic Leukemia
  • +2 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Dec 16, 2022

Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma, Myeloid Leukemia Trial in Detroit (Dasatinib, laboratory biomarker analysis)

Terminated
  • Non-Hodgkin's Lymphoma
  • +5 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Dec 14, 2020

Solid Tumor Trial in Washington (ixabepilone, Dasatinib)

Completed
  • Solid Tumor
  • Washington, District of Columbia
    Washington Cancer Institute
Aug 3, 2020

Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Seattle (drug, other, biological)

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • Lymphoblastic Lymphoma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jun 18, 2022

Lung Cancer, NSCLC (NSCLC) Trial in Tampa (Dasatinib - 1A, Afatinib - 1A, Dasatinib - 1B)

Completed
Has Results
  • Lung Cancer
  • Non-small Cell Lung Cancer (NSCLC)
  • Dasatinib - 1A
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 24, 2020

Leukemia Trial in Houston (Dasatinib, Decitabine)

Terminated
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 29, 2020

Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Dasatinib)

Withdrawn
  • Advanced Lymphoma
  • +5 more
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Jul 17, 2020

Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission, Minimal Residual

Terminated
  • Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 1, 2020

Non-Hodgkin's Lymphoma, Multiple, Mycosis Fungoides Trial in Detroit (Dasatinib)

Terminated
  • Non-Hodgkin's Lymphoma
  • +4 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Mar 12, 2020